Get the Stockscreener App
13.36
0.15%
0.02
Pre-market:
13.34
-0.02
-0.15%
Organon Co stock is traded at $13.36, with a volume of 3.53M.
It is up +0.15% in the last 24 hours and up +0.53% over the past month.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
See More
Previous Close:
$13.34
Open:
$13.37
24h Volume:
3.53M
Relative Volume:
0.42
Market Cap:
$3.51B
Revenue:
$6.16B
Net Income/Loss:
$246.00M
P/E Ratio:
14.23
EPS:
0.9387
Net Cash Flow:
$708.00M
1W Performance:
-0.52%
1M Performance:
+0.53%
6M Performance:
+75.79%
1Y Performance:
+44.90%
1-Day Range:
$13.35
$13.40
1-Week Range:
$13.34
$13.44
52-Week Range:
$5.69
$13.48
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.36 | 3.50B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,082.20 | 985.37B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
223.51 | 542.42B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
212.93 | 384.67B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
115.17 | 293.22B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
179.71 | 287.95B | 60.48B | 10.40B | 8.05B | 3.3297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Oct-27-25 | Downgrade | Piper Sandler | Overweight → Underweight |
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Sun Pharma, Organon filed HSR May 21, waiting period expires June 22 - MLex
Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share - Stock Titan
Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip - The Ken
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Top Organon & Co. (OGN) Competitors 2026 - MarketBeat
Organon (OGN) Holds Near Support at $13.35 as Stock ConsolidatesInsider Selling Alerts - thelegaladvocate.com
Organon & Co stock (US68622V1061): Shares trade quietly as investors await next catalysts - AD HOC NEWS
Organon & Co is the best performing healthcare stock in April - MSN
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
Organon Stock Holds Steady Near Support as Consolidation ContinuesPCR Spike - thelegaladvocate.com
(OGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Organon Audit Cleared And New Data Put Valuation And Risks In Focus - Yahoo Finance
Sun Pharma to Acquire Organon for $11.75 Billion in All-Cash Transaction - The Healthcare Technology Report.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
Organon & Co. (OGN) Q1 2026 Earnings: EPS Falls Short of Estimates Amid Challenging Environment - thelegaladvocate.com
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal - The Economic Times
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático - GlobeNewswire Inc.
Organon to supply Hanmi’s 3 combo drugs in Malaysia, Philippines - koreabiomed.com
What Sparked Organon's Recent Stock Surge - Kavout
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia - Macau Business
Organon (OGN) price target increased by 25.58% to 11.02 - MSN
10 Incredible Facts About Sun Pharma’s Historic $11.75 Billion Organon Acquisition - AOL.com
Organon & Co. (OGN) Leads Mid-Cap Stocks with Low Forward P/E Ra - GuruFocus
Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy - MSN
Organon & Co stock hits 52-week high at $13.44 By Investing.com - Investing.com Nigeria
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
Organon & Co stock hits 52-week high at $13.44 - Investing.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
1OGN.MI Stock Price, Quote & Chart | ORGANON & CO (BIT:1OGN) - ChartMill
Organon to Present New Research on Access and Value at ISPOR 2026 - BioSpace
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
Why is OGN stock rising in pre-market today? - MSN
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Raises Stock Holdings in Organon & Co. $OGN - MarketBeat
BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):